KIF5A and myeloid sarcoma: This effect was confirmed in multivariate analysis (p < 0.01), which also revealed a significant difference in levels of CSF KIF5A between CIS and progressive MS samples when accounting for additional independent cohort variables (p < 0.01; Table 4).